These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10674594)

  • 1. Estrogen effects on postural balance in postmenopausal women without vasomotor symptoms: a randomized masked trial.
    Ekblad S; Lönnberg B; Berg G; Odkvist L; Ledin T; Hammar M
    Obstet Gynecol; 2000 Feb; 95(2):278-83. PubMed ID: 10674594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of hormonal replacement therapy on the postural balance among postmenopausal women.
    Hammar ML; Lindgren R; Berg GE; Möller CG; Niklasson MK
    Obstet Gynecol; 1996 Dec; 88(6):955-60. PubMed ID: 8942834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of estrogen therapy on well-being in postmenopausal women without vasomotor complaints.
    Skarsgård C; E Berg G; Ekblad S; Wiklund I; Hammar ML
    Maturitas; 2000 Aug; 36(2):123-30. PubMed ID: 11006499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lowest effective transdermal 17beta-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trial.
    Bachmann GA; Schaefers M; Uddin A; Utian WH
    Obstet Gynecol; 2007 Oct; 110(4):771-9. PubMed ID: 17906008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmenopausal women without previous or current vasomotor symptoms do not flush after abruptly abandoning estrogen replacement therapy.
    Hammar M; Ekblad S; Lönnberg B; Berg G; Lindgren R; Wyon Y
    Maturitas; 1999 Jan; 31(2):117-22. PubMed ID: 10227004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study.
    Santoro N; Allshouse A; Neal-Perry G; Pal L; Lobo RA; Naftolin F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Dowling NM; Dunn M; Gleason CE; Hodis HN; Isaac B; Magnani M; Manson JE; Miller VM; Taylor HS; Wharton W; Wolff E; Zepeda V; Harman SM
    Menopause; 2017 Mar; 24(3):238-246. PubMed ID: 27779568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transition from estrogen-progestin to raloxifene in postmenopausal women: effect on vasomotor symptoms.
    Gordon S; Walsh BW; Ciaccia AV; Siddhanti S; Rosen AS; Plouffe L
    Obstet Gynecol; 2004 Feb; 103(2):267-73. PubMed ID: 14754694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of estrogen therapy on postmenopausal sleep quality regardless of vasomotor symptoms: a randomized trial.
    Tansupswatdikul P; Chaikittisilpa S; Jaimchariyatam N; Panyakhamlerd K; Jaisamrarn U; Taechakraichana N
    Climacteric; 2015 Apr; 18(2):198-204. PubMed ID: 25242569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids.
    Rozenberg S; Ylikorkala O; Arrenbrecht S
    Int J Fertil Womens Med; 1997; 42 Suppl 2():376-87. PubMed ID: 9397385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose estradiol spray to treat vasomotor symptoms: a randomized controlled trial.
    Buster JE; Koltun WD; Pascual ML; Day WW; Peterson C
    Obstet Gynecol; 2008 Jun; 111(6):1343-51. PubMed ID: 18515518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose transdermal estradiol for vasomotor symptoms: a systematic review.
    Corbelli J; Shaikh N; Wessel C; Hess R
    Menopause; 2015 Jan; 22(1):114-21. PubMed ID: 24977458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasomotor hot flashes and heart rate variability: a placebo-controlled trial of postmenopausal hormone therapy.
    Lantto H; Haapalahti P; Tuomikoski P; Viitasalo M; Väänänen H; Sovijärvi AR; Ylikorkala O; Mikkola TS
    Menopause; 2012 Jan; 19(1):82-8. PubMed ID: 21934534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasomotor hot flushes and 24-hour ambulatory blood pressure in normotensive women: A placebo-controlled trial on post-menopausal hormone therapy.
    Tuomikoski P; Haapalahti P; Sarna S; Ylikorkala O; Mikkola TS
    Ann Med; 2010 Jul; 42(5):334-43. PubMed ID: 20429800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years.
    Diem S; Grady D; Quan J; Vittinghoff E; Wallace R; Hanes V; Ensrud K
    Menopause; 2006; 13(1):130-8. PubMed ID: 16607109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early postmenopausal hormone therapy improves postural balance.
    Naessen T; Lindmark B; Lagerström C; Larsen HC; Persson I
    Menopause; 2007; 14(1):14-9. PubMed ID: 17091024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microdose transdermal estrogen therapy for relief of vulvovaginal symptoms in postmenopausal women.
    Bachmann GA; Schaefers M; Uddin A; Utian WH
    Menopause; 2009; 16(5):877-82. PubMed ID: 19458560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estradiol in micellar nanoparticles: the efficacy and safety of a novel transdermal drug-delivery technology in the management of moderate to severe vasomotor symptoms.
    Simon JA;
    Menopause; 2006; 13(2):222-31. PubMed ID: 16645536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy and safety of estradiol transdermal preparations for the treatment of vasomotor symptoms in postmenopausal women: an indirect comparison meta-analysis.
    Derzko C; Sergerie M; Siliman G; Alberton M; Thorlund K
    Menopause; 2016 Mar; 23(3):294-303. PubMed ID: 26382309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perimenopausal women in estrogen vasomotor trials: contribution to placebo effect and efficacy outcome.
    Simon JA; Stevens RE; Ayres SA; Phelps KV
    Climacteric; 2001 Mar; 4(1):19-27. PubMed ID: 11379374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, placebo-controlled study of the lowest effective dose of drospirenone with 17β-estradiol for moderate to severe vasomotor symptoms in postmenopausal women.
    Archer DF; Schmelter T; Schaefers M; Gerlinger C; Gude K
    Menopause; 2014 Mar; 21(3):227-35. PubMed ID: 23963307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.